$5.74
-2.0%LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation
Base year metrics used for projections
Forecast period and terminal assumptions
Calculation flow from present value to intrinsic value per share
Operating Cash Flow - Maintenance CapEx = Owner Earnings
| Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 | Year 7 | Year 8 | Year 9 | Year 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$7.4M | -$3.7M | -$1.9M | -$926.9K | -$463.5K | -$231.7K | -$115.9K | -$57.9K | -$29.0K | -$14.5K |
| Maintenance CapEx | -$8.3K | -$4.2K | -$2.1K | -$1.0K | -$519 | -$259 | -$130 | -$65 | -$32 | -$16 |
| Owner Earnings | -$7.4M | -$3.7M | -$1.9M | -$928.0K | -$464.0K | -$232.0K | -$116.0K | -$58.0K | -$29.0K | -$14.5K |
| Discount Factor | 0.926 | 0.857 | 0.794 | 0.735 | 0.681 | 0.630 | 0.583 | 0.540 | 0.500 | 0.463 |
| Present Value | -$6.9M | -$3.2M | -$1.5M | -$682.1K | -$315.8K | -$146.2K | -$67.7K | -$31.3K | -$14.5K | -$6.7K |
Continue your LNSR research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.